Spots Global Cancer Trial Database for anaplastic ependymoma
Every month we try and update this database with for anaplastic ependymoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma | NCT04978727 | Medulloblastoma Glioblastoma Mu... Anaplastic Astr... High-grade Astr... Anaplastic Olig... Anaplastic Epen... Ependymoma Diffuse Intrins... | SurVaxM for pat... SurVaxM for pat... SurVaxM for pat... | 1 Year - 21 Years | Pediatric Brain Tumor Consortium | |
| Carboplatin and Bevacizumab for Recurrent Ependymoma | NCT01295944 | Ependymoma Anaplastic Epen... | Carboplatin Bevacizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients | NCT00876499 | Brain Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 | NCT01082926 | Anaplastic Astr... Anaplastic Epen... Anaplastic Meni... Anaplastic Olig... Brain Stem Glio... Ependymoblastom... Giant Cell Glio... Glioblastoma Gliosarcoma Grade III Menin... Meningeal Heman... Mixed Glioma Pineal Gland As... Brain Tumor | therapeutic all... aldesleukin laboratory biom... positron emissi... | 18 Years - 70 Years | City of Hope Medical Center | |
| Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma | NCT01095094 | Brain Tumor Anaplastic Astr... Anaplastic Epen... Anaplastic Olig... Brain Stem Glio... Giant Cell Glio... Glioblastoma Gliosarcoma Mixed Glioma | ritonavir lopinavir | 18 Years - | Case Comprehensive Cancer Center | |
| Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma | NCT02101905 | Anaplastic Astr... Anaplastic Epen... Anaplastic Olig... Gliosarcoma Mixed Glioma Recurrent Adult... Recurrent Gliob... | Laboratory Biom... Lapatinib Lapatinib Ditos... Pharmacological... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Antineoplaston Therapy in Treating Patients With Ependymoma | NCT00003479 | Ependymoma | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors | NCT00243490 | Malignant Intra... Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Epen... | Photodynamic th... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors | NCT00243490 | Malignant Intra... Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Epen... | Photodynamic th... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Antineoplaston Therapy in Treating Patients With Ependymoma | NCT00003479 | Ependymoma | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Everolimus for Children With Recurrent or Progressive Ependymoma | NCT02155920 | Recurrent Child... | Everolimus | 2 Years - 21 Years | University of Texas Southwestern Medical Center | |
| Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | NCT01096368 | Anaplastic Epen... Brain Ependymom... Cellular Ependy... Clear Cell Epen... Ependymoma Papillary Epend... | 3-Dimensional C... Carboplatin Cisplatin Clinical Observ... Cyclophosphamid... Etoposide Filgrastim Laboratory Biom... Mesna Vincristine | 12 Months - 21 Years | Children's Oncology Group | |
| Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors | NCT01836549 | Anaplastic Astr... Anaplastic Epen... Astrocytoma, Gr... Ependymoma Giant Cell Glio... Glioblastoma Gliosarcoma Oligodendroglio... Brainstem Tumor... | imetelstat sodi... | 12 Months - 21 Years | Pediatric Brain Tumor Consortium | |
| Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma | NCT02101905 | Anaplastic Astr... Anaplastic Epen... Anaplastic Olig... Gliosarcoma Mixed Glioma Recurrent Adult... Recurrent Gliob... | Laboratory Biom... Lapatinib Lapatinib Ditos... Pharmacological... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors | NCT01836549 | Anaplastic Astr... Anaplastic Epen... Astrocytoma, Gr... Ependymoma Giant Cell Glio... Glioblastoma Gliosarcoma Oligodendroglio... Brainstem Tumor... | imetelstat sodi... | 12 Months - 21 Years | Pediatric Brain Tumor Consortium | |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas | NCT01721577 | Glioblastoma Gliosarcoma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Anaplastic Epen... | AXL1717 | 18 Years - | Rush University Medical Center | |
| Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma | NCT03727841 | Anaplastic Epen... Ependymoma Ependymomas | Marizomib | - | National Institutes of Health Clinical Center (CC) | |
| Carboplatin and Bevacizumab for Recurrent Ependymoma | NCT01295944 | Ependymoma Anaplastic Epen... | Carboplatin Bevacizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | NCT01096368 | Anaplastic Epen... Brain Ependymom... Cellular Ependy... Clear Cell Epen... Ependymoma Papillary Epend... | 3-Dimensional C... Carboplatin Cisplatin Clinical Observ... Cyclophosphamid... Etoposide Filgrastim Laboratory Biom... Mesna Vincristine | 12 Months - 21 Years | Children's Oncology Group | |
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors | NCT05278208 | High Grade Glio... Meningioma Embryonal Tumor Medulloblastoma Anaplastic Epen... Recurrent Diffu... Recurrent Malig... Recurrent Medul... Recurrent Prima... Refractory Diff... Refractory Mali... Refractory Medu... Refractory Prim... | LUTATHERA® (Lut... | 4 Years - | Nationwide Children's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
